...
首页> 外文期刊>Journal of nanoscience and nanotechnology >Nanosized and Nanostructured Particles in Pulmonary Drug Delivery
【24h】

Nanosized and Nanostructured Particles in Pulmonary Drug Delivery

机译:肺部药物输送中的纳米尺寸和纳米结构颗粒。

获取原文
获取原文并翻译 | 示例
           

摘要

Nanosized objects can be used as the drug carriers with specific functionalities which are introduced to the body via the respiratory system, i.e., by inhalation. They can be carried in as aerosol nanoparticles (NPs), nanostructured particles (NSPs) or components of nanosuspensions atomized into micrometer-sized droplets. In the first part of the paper physical factors required for the effective inhalation of nanocarriers are discussed, including the flow dynamics of NPs and NSPs in the respiratory tract. Selected problems related to designing of the required properties of inhalable drug carriers are also addressed. In the next part of the paper, the importance of direct physicochemical interactions between deposited nanoparticles and pulmonary fluids (pulmonary surfactant and bronchial mucus) is emphasized. This perspective allows for a more rational definition of the efficient strategies of the delivery of nanoparticle drug carriers via inhalation.
机译:纳米物体可用作具有特定功能的药物载体,其通过呼吸系统,即通过吸入引入人体。它们可以雾化成气溶胶纳米颗粒(NPs),纳米结构颗粒(NSPs)或纳米悬浮液的成分,并雾化成微米大小的液滴。在论文的第一部分中,讨论了有效吸入纳米载体所需的物理因素,包括呼吸道中NP和NSP的流动动力学。还解决了与可吸入药物载体的所需特性设计有关的选定问题。在本文的下一部分中,强调了沉积的纳米颗粒与肺液(肺表面活性剂和支气管粘液)之间直接物理化学相互作用的重要性。该观点允许通过吸入递送纳米颗粒药物载体的有效策略的更合理定义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号